Remove 2025 Remove enablement Remove ventures
article thumbnail

Revolution Ventures Invests in Oula, the Maternity Care Startup Combining the Best of Obstetrics…

Revolution

Revolution Ventures Invests in Oula, the Maternity Care Startup Combining the Best of Obstetrics and Midwifery Oula will use the $28M Series B to open additional clinics and launch new services. Its tech-enabled offering is further augmented with virtual wrap-around services and group support. employer of midwives.

ventures 246
article thumbnail

Creator Ventures Raises $45M Fund II to Back the Next Generation of Consumer Internet Startups

American Entrepreneurship

Creator Ventures, founded in 2022 by cousins Sasha Kaletsky and Caspar Lee , is uniquely positioned to invest in the next wave of AI-enabled consumer applications, marketplaces, creative tools, and SaaS platforms reshaping the digital landscape. Thats what we bring. Its Fund I (20222025) already shows 0.3x

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Qolab’s Funding from Applied Ventures Advances Quantum Computing Manufacturing

American Entrepreneurship

a pioneering company in quantum computing hardware, has secured a significant investment from Applied Ventures, LLC, the venture capital arm of Applied Materials, Inc. With the support of Applied Ventures and other industry partners, Qolab is well-positioned to push the boundaries of what is possible in quantum technology.

article thumbnail

Disruptive Technology Startups Selected for Morgan Stanley’s Inclusive Ventures Lab

American Entrepreneurship

The global financial services firm narrowed its selection down to 25 companies for its I nclusive Ventures Lab. These technology-enabled startups are in the seed to Series A funding round stage, tackling a wide range of global challenges and needing access to resources. Twelve U.S.-based

article thumbnail

Revolution Growth’s Latest Investment in Healthcare and AI: Pathos, the Company Re-Engineering the…

Revolution

Meet Pathos  — the clinical-stage, AI-enabled biotech company that is re-engineering the drug development process to bring novel drugs to market. The Results To-Date: In the last 12 months, Pathos has acquired two clinical-stage precision oncology assets with plans to launch their Phase II clinical trials in 2025.

investing 100
article thumbnail

Glean’s $150M Series F Accelerates Global Adoption of Enterprise AI Agents

American Entrepreneurship

This round includes both new backers like Khosla Ventures, Bicycle Capital, Geodesic Capital, and Archerman Capital, alongside continued support from existing top-tier investors including Sequoia Capital, Kleiner Perkins, General Catalyst, and Lightspeed Venture Partners.

article thumbnail

Opaque Systems secures cash to keep data private while enabling collaboration

TechCrunch

Opaque Systems , a startup developing what it describes as “AI for confidential computing,” today announced that it closed a $22 million Series A funding round led by Walden Catalyst Partners with participation from Storm Ventures, Thomvest Ventures, Intel Capital, Race Capital, The House Fund, and FactoryHQ.